Recombinant Human Tau-E/1N4R Protein

Tau-E/1N4R recombinant protein is a significant focus in neurodegenerative disease research, particularly in the study of tauopathies such as Alzheimer's disease. Tau is a microtubule-associated protein primarily found in neurons, playing a crucial role in stabilizing microtubules, which are vital for maintaining neuronal structure and function. In various tauopathies, tau protein undergoes hyperphosphorylation, leading to the formation of neurofibrillary tangles and synaptic dysfunction. The Tau-E isoform, specifically, represents an alternative splicing variant with an extended C-terminal domain that is implicated in tau aggregation and pathogenesis. The 1N4R variant refers to the presence of one repeat and four microtubule-binding domains in the tau protein structure, which is associated with increased neurotoxicity. Research on Tau-E/1N4R recombinant protein aims to elucidate the biochemical properties and aggregation mechanisms of tau protein in disease states. Understanding these mechanisms can foster the development of targeted therapeutics, such as tau-targeted antibodies or small molecule inhibitors, which could help prevent or mitigate tau aggregation and improve clinical outcomes for affected individuals. Furthermore, the use of recombinant versions of tau proteins allows for detailed structural and functional studies, facilitating insights into interactions with other cellular components, signaling pathways, and potential biomarkers for disease progression. Overall, the study of Tau-E/1N4R recombinant protein is crucial in advancing our knowledge of tau pathology and developing effective treatments for tau-related neurodegenerative diseases.